Noncoding RNAs in Calcific Aortic Valve Disease: A Review of Recent Studies

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Genetics

Background:

• Calcific aortic valve disease (CAVD) is the most prevalent heart valve disorder globally.
• Current therapeutic options for CAVD are limited, highlighting the need for better understanding of its underlying mechanisms.
• Gene expression regulation is vital for maintaining cardiovascular tissue health, and its dysregulation contributes to disease pathology.

Purpose of the Study:

• To summarize the current knowledge on the involvement of noncoding RNAs in CAVD.
• To highlight the roles of microRNAs and long noncoding RNAs in the pathogenesis and progression of CAVD.
• To provide a guide for future research strategies and identify potential biomarkers for CAVD.

Main Methods:

• Literature review and synthesis of existing research on noncoding RNAs and CAVD.
• Analysis of the contribution of various noncoding RNA classes to CAVD.
• Identification of key regulatory mechanisms involving noncoding RNAs in cardiovascular tissues.

Main Results:

• Noncoding RNAs, such as microRNAs and long noncoding RNAs, are increasingly recognized for their significant roles in CAVD.
• These regulatory elements are implicated in both the onset and prognosis of calcific aortic valve disease.
• Evidence suggests noncoding RNAs are critical players in the pathological mechanisms driving CAVD.

Conclusions:

• Noncoding RNAs represent a key area of focus for understanding and potentially treating CAVD.
• Further research into noncoding RNA functions in CAVD could lead to novel therapeutic targets.
• This review provides a foundation for identifying new CAVD biomarkers and advancing research strategies.